Welcome to BeiMedPlus

BeiGene's medical website with resources for healthcare professionals and disease information for patients and caregivers.

Please confirm the option below that best describes you so we can direct you to appropriate resources and information.

I am a...

Healthcare Professional

hcp

Patient / Caregiver

patient

BeiGene Employee

employee

I am from...

GLOBAL (ex-US) / EN

pts-en

France / FR

Germany / DE

Italy / IT

pts-it

Spain / ES

Sweden / SE

Switzerland / DE

ch-de

Switzerland / FR

ch-fr

Switzerland / IT

ch-it

United States / EN

Select Your Location:

Global

France

Germany

Italy

Switzerland DE | FR | IT

Spain

Sweden

Resource Center
- Events Calendar
- Congress Resources
BeiGeneius
Disease Education
- Hematologic Malignancies
- Solid Tumors
Clinical Studies
Contact Us

Choose Language

English

EHA2023 Hybrid Congress Satellite Symposium: Improving outcomes for CLL patients – from promising research to current advances in daily practice

Category: Video

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Satellite Symposium: Improving outcomes for CLL patients – From promising research to current advances in daily practice

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

Video

18 Jul 2023

Tislelizumab MoA

Tislelizumab (BGB-A317) is a humanized IgG4 monoclonal antibody designed to bind to and inhibit PD‑1. Watch the MoA video to learn more

Video

6 Apr 2022

Posts navigation

Newer posts

This website is intended for Healthcare Professionals for scientific information exchange purposes only, not for advertising purposes, and does not constitute commercial promotion of any product or recommendation on diagnosis and treatments.

The website may contain information about products or indications that have not yet been approved in your country; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

The safety and efficacy of investigational products or uses may not have been established. Because of the uncertainty of clinical trials, there is no guarantee that compounds will receive regulatory approval and become commercially available for the uses being investigated.

REPORT AN ADVERSE EVENT

adverse_event@beigene.com
Contact Us by Phone

REPORT A PRODUCT COMPLAINT

productscomplaints@beigene.com
Contact Us by Phone

About Us
Privacy Policy
Terms of Use

Information for patients

memo inOncology

OncologyPro

You're now leaving the website www.beimedplus.com

This link is provided for information purposes only. Please be aware that, if you click on it, you will leave www.beimedplus.com website. The link will take you to another BeiGene website, the content of which is subject to the locally applicable laws and regulations.

BeiGene Switzerland GmbH makes no representation that the information provided on the website is suitable or available for use or access in locations outside the country for which the website is intended.

Please ensure that you belong to the target group of the content provided on the linked website and that your access to it complies with the applicable laws and regulations.

No, I want to go back Yes, I would like to continue

You're now leaving the website www.beimedplus.com

This link is provided for information purposes only. Please be aware that, if you click on it, you will leave www.beimedplus.com website. The link will take you to a website owned and operated by an independent party over which BeiGene Switzerland GmbH has no control or influence (“third-party website”).

BeiGene Switzerland GmbH makes no representation that information on the third-party website is appropriate or available for use or access in locations outside the country for which the third-party website is intended. Therefore, BeiGene Switzerland GmbH declines any responsibility for third-party information. BeiGene Switzerland GmbH makes no representation regarding the data usage policies of the third party website and declines any responsibility for the use of personal data by the operator of the third-party website. Please ensure that you belong to the intended audience of the content provided on third-party website and that your access to it complies with the applicable laws and regulations.

Do you really want to leave the www.beimedplus.com website?

No, I want to go back Yes, I would like to continue